CVS Health Announces Pharmacy and Consumer Wellness Leadership Appointments
CVS Health Announces Pharmacy and Consumer Wellness Leadership Appointments
WOONSOCKET, R.I., December 3, 2024 — CVS Health (NYSE: CVS) today announced that Len Shankman will be president, Pharmacy and Consumer Wellness (PCW), reporting to Prem Shah, group president, CVS Health. In addition, the company announced the appointment of Lucille Accetta, RPh, MPH, MBA as chief pharmacy officer, also reporting to Shah. Both appointments are effective immediately.
伍伦索克,罗德岛,2024年12月3日 — 西维斯健康(纽交所:CVS)今天宣布,伦·香克曼将担任药房与消费健康(PCW)总裁,向西维斯健康集团总裁普瑞姆·沙阿汇报。此外,公司还宣布任命鲁西尔·阿切塔为首席药房官,亦向沙阿汇报。这两项任命立即生效。
As president, Pharmacy and Consumer Wellness, Shankman will oversee the front store and retail pharmacy businesses across the company's more than 9,000 CVS Pharmacy locations. In his new role, Shankman will lead the team in continuing to deliver integrated digitally-led experiences that address consumer's health and wellness needs when and where they need us.
作为药房和消费健康的总裁,Shankman将监督公司在超过9,000个西维斯药房地点的前台和零售药房业务。在新的角色中,Shankman将带领团队继续提供集成的数字驱动体验,满足消费者在需要我们的时候和地方的健康和保健需求。
Shankman joined CVS Health in 2002 and has held positions of increasing responsibility, most recently serving as senior vice president and chief financial officer, Pharmacy and Consumer Wellness. Shankman has also held leadership positions in the company's Specialty Pharmacy business and as general manager for Coram, the CVS Specialty infusion business. Before joining CVS Health, Shankman served in the United States Navy.
Shankman于2002年加入西维斯健康,曾担任多个逐步增加责任的职位,最近担任药房和消费健康的高级副总裁兼首席财务官。Shankman在公司的专科药房业务和作为Coram西维斯专科输液业务的总经理岗位上也曾担任领导职务。在加入西维斯健康之前,Shankman曾在美国海军服役。
"Len has a deep knowledge of our Pharmacy and Consumer Wellness business and our company, and his focus on strategy execution, operational strength, and financial performance will help us continue to lead in the market," said CVS Health president and CEO David Joyner. "His disciplined, strategic guidance will further position CVS Pharmacy as a trusted resource for the communities we serve."
“Len对我们的药房和消费健康业务以及公司有深刻的了解,他对策略执行、运营实力和财务表现的关注将帮助我们继续在市场上保持领先,”西维斯健康总裁兼首席执行官David Joyner说道。“他严谨的战略指导将进一步使西维斯药房成为我们服务社区的可靠资源。”
As chief pharmacy officer, Accetta will advocate for the role of the pharmacist in health care and will be responsible for creating and implementing strategic opportunities to connect our pharmacy assets across the CVS Health enterprise. She will also continue to oversee the Specialty Pharmacy, Coram and Omnicare businesses in her role as senior vice president, Specialty Pharmacy Operations.
作为首席药学官,Accetta将为药剂师在医疗保健中的角色倡导,并将负责创建和实施战略机会,以连接我们在西维斯健康企业中的药房资产。她还将继续在专科药房、Coram和Omnicare业务中担任高级副总裁,专注于专科药房运营。
Since joining CVS Health in 2017, Accetta has held roles with increasing responsibility within the Specialty Pharmacy business. Prior to joining the company, she held leadership roles at Teva Pharmaceuticals, Rx Ally, Express Scripts and Medco, building her skills in patient services management, pharmacy product development and clinical operations.
自2017年加入西维斯健康以来,Accetta在专科药房业务中担任了越来越多责任的职位。在加入公司之前,她曾在Teva制药、Rx Ally、Express Scripts和Medco担任领导职务,提升了她在患者服务管理、药房产品开发和临床运营方面的技能。
"Our specialty pharmacy is entrusted with the care of people who are facing challenging and complex diagnoses, and Lucille leads with heart, driving the operational excellence our patients deserve along with instilling in our team an unwavering focus on caring for patients," said Joyner. "Her passion and commitment to the practice of pharmacy make her an excellent advocate for the profession."
"我们的专科药房承担着面对具有挑战性和复杂诊断患者的护理,Lucille用心领导,推动我们的患者应得的运营卓越,同时在我们的团队中灌输对患者关怀的坚定专注," Joyner说道。"她对药房实践的热情和承诺使她成为这份职业的优秀倡导者。"
On its most recent earnings call, the company highlighted recent positive trends in the Pharmacy and Consumer Wellness business:
在最新的业绩会上,公司强调了药品和消费健康业务的积极趋势:
Our performance reflects strong execution and the benefit of strategic investments in both our workflows and our colleagues.
我们的业绩反映了强有力的执行力和在工作流程和同事方面的战略投资带来的好处。
We have achieved record high retail pharmacy prescription share of 27.3 percent.
我们在零售药房处方份额上达到了27.3%的历史高点。
We continue to progress in the transition to the CVS CostVantage model, having reached agreements covering more than half of our total commercial prescriptions.
我们在向CVS CostVantage模型过渡的过程中不断取得进展,已达成覆盖一半以上的商业处方协议。
About CVS Health
关于西维斯健康
CVS Health is the leading health solutions company, delivering care like no one else can. We reach more people and improve the health of communities across America through our local presence, digital channels and over 300,000 dedicated colleagues — including more than 40,000 physicians, pharmacists, nurses and nurse practitioners. Wherever and whenever people need us, we help them with their health — whether that's managing chronic diseases, staying compliant with their medications or accessing affordable health and wellness services in the most convenient ways. We help people navigate the health care system — and their personal health care — by improving access, lowering costs and being a trusted partner for every meaningful moment of health. And we do it all with heart, each and every day. Follow @CVSHealth on social media.
CVS Health是领先的健康解决方案公司,通过我们的本地存在、数字渠道和超过300,000名专职同事——包括超过40,000名医生、药剂师、护士和执业护士——接触到更多的人,并通过我们的本地存在、数字渠道和超过300,000名专职同事,提高了美国社区的健康状况。无论何时何地,人们需要我们,在关键时刻,我们帮助他们管理慢性疾病,遵守他们的药物治疗,或以最方便的方式接触到负担得起的健康和健身服务。我们帮助人们在健康护理系统中导航,并改善他们的个人医疗保健,提供帮助,降低成本,并成为每一个重要的健康时刻的可靠伙伴。我们每天都充满热情地关心所有人。在社交媒体上关注@CVSHealth。
Media contact
媒体联系人
Ethan Slavin
860-273-6095
Ethan.Slavin@CVSHealth.com
伊桑·斯拉文
860-273-6095
Ethan.Slavin@CVSHealth.com
Investor contact
投资者联系人
Larry McGrath
800-201-0938
InvestorInfo@CVSHealth.com
拉里·麦格拉思
800-201-0938
InvestorInfo@CVSHealth.com